Salonpas Arthritis Pain

Manufacturer: Hisamitsu Pharmaceutical Co., Inc.
Effective date: 2025-03-14
Label type: HUMAN OTC DRUG LABEL
Version: 5
Source: full-release
Hydrated at: 2026-06-01 00:57:08

Label at a glance#

ProductSalonpas Arthritis Pain

Active ingredientMENTHOL, METHYL SALICYLATE

Label structure10 sections

Indications and uses

Temporarily relieves mild to moderate aches and pains of muscles and joints associated with: arthritis sprains strains bruises simple backache

Dosage and administration

Adults 18 years and older: only use one patch at a time clean and dry affected area remove patch from backing film and apply to skin (see illustration) apply one patch to the affected area and leave in place for up to 8 to 12 hours if pain lasts after using the first patch, a second patch may be applied for up to another 8 to 12 hours do not use more than 2 patches per day do not use for more than 3 days in a row ...

Storage and handling

store at 20 - 25 degrees Celsius (68-77 degrees Fahrenheit) avoid storing product in direct sunlight protect product from excessive moisture some individuals may not experience pain relief until several hours after applying the patch

Contacts and useful links#

Websitewww.salonpas.us

www.salonpas.us

Label contents#

Full prescribing information#

Active ingredients (in each patch)

OTC - ACTIVE INGREDIENT SECTION

Menthol 3%

Methyl salicylate 10% (NSAID : nonsteroidal anti-inflammatory drug)

Purpose

OTC - PURPOSE SECTION

Topical analgesic

Uses

INDICATIONS & USAGE SECTION

Temporarily relieves mild to moderate aches and pains of muscles and joints associated with:

arthritis
sprains
strains
bruises
simple backache

Warnings

WARNINGS SECTION

For external use only

Stomach bleeding warning:

USER SAFETY WARNINGS SECTION

This product contains an NSAID, which may cause stomach bleeding. The chance is small but higher if you:

are age 60 or older
have had stomach ulcers or bleeding problems
take a blood thinning (anticoagulant) or steroid drug
take other drugs containing an NSAID [aspirin, ibuprofen, naproxen, or others]
have 3 or more alcoholic drinks every day while using this product
take more or for a longer time than directed

Do not use

OTC - DO NOT USE SECTION

on the face or rashes
on wouds or damaged skin
if allergic to aspirin or other NSAIDs
with a heating pad
when sweating (such as from exercise or heat)
any patch from a pouch that has been open for 14 or more days
right before or after heart surgery

Ask a doctor before use if

OTC - ASK DOCTOR SECTION

you are allergic to topical products
the stomach bleeding warning applies to you
you are taking a diuretic
you have high blood pressure, heart disease, or kidney disease

When using this product

OTC - WHEN USING SECTION

wash hands after applying or removing patch. Avoid contact with eyes. If eye contact occurs, rinse thoroughly with water.
the risk of heart attack or stroke may increase if you use more than directed or for longer than directed

Stop use and ask a doctor if

OTC - STOP USE SECTION

stomach pain or upset gets worse or lasts
you feel faint, vomit blood, or have bloody or black stools. These are signs of stomach beeding.
rash, itching or skin irritaion develops
condition worsens
symptoms last for more than 3 days
symptoms clear up and occur again within a few days

If pregnant or breast-feeding,

OTC - PREGNANCY OR BREAST FEEDING SECTION

ask a health professional before use. It is especially important not to use methyl salicylate at 20 weeks or later in pregnancy unless definitely directed to do so by a doctor because it may cause problems in the unborn child or complications during delivery.

Keep out of reach of children.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

If put in mouth, get medical help or contact a Poison Control Center right away. Package not child resistant. Dispose of the used patches after folding sticky ends together.

Directions

DOSAGE & ADMINISTRATION SECTION

Adults 18 years and older:

only use one patch at a time
clean and dry affected area
remove patch from backing film and apply to skin (see illustration)
apply one patch to the affected area and leave in place for up to 8 to 12 hours
if pain lasts after using the first patch, a second patch may be applied for up to another 8 to 12 hours
do not use more than 2 patches per day
do not use for more than 3 days in a row
the used patch should be removed from the skin when a new one is applied

Children under 18 years of age: do not use; this product has not been shown to work in children

Other information

STORAGE AND HANDLING SECTION

store at 20 - 25 degrees Celsius (68-77 degrees Fahrenheit)
avoid storing product in direct sunlight
protect product from excessive moisture
some individuals may not experience pain relief until several hours after applying the patch

Inactive inredients

INACTIVE INGREDIENT SECTION

alicyclic saturated hydrocarbon resin, baking cloth, film, mineral oil, polyisobutylene, polyisobutylene 1,200,000, styrene-isoprene-sryrene block copolymer, synthetic aluminum silicate

Questions or comments?

OTC - QUESTIONS SECTION

Toll free 1-87-SALONPAS www.salonpas.us

Principal Display Panel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Hisamitsu

NDC#46581-680-20

for temporary relief of mild to moderate pain

Arthritis
Joint Pain
Sprains
Strains

Salonpas

Arthritis Pain Patch

APPLY FOR 8-12 HOURS

Menthol 3%

Methyl Salicylate 10%

Topical Analgesic

FDA APPROVED NON-PRESCRIPTION PAIN RELIEVING PATCH

EFFECTIVENESS CONFIRMED IN CLINICAL TRIAL

20 pathces

2 3/4" X 3 15/16"(7cm X 10cm)

Package not child resistant.

Keep our of reach of children.

* DO NOT USE MORE THAN ONE SALONPAS PATCH AT A TIME. SEE DIRECTIONS

image of 20-patch box label

Principal Display Panel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

NDC#46581-680-99

for temporary relief of mild to moderate pain

Arthritis
Joint Pain
Sprains
Strains

HOW TO APPLY
1 Peel the center film.
2 Place on affected area.
3 Slide the film upward.
4 Slide the other film downward.

Salonpas
Arthritis Pain Patch

APPLY FOR 8-12 HOURS

Menthol 3%
Methyl Salicylate 10%
Topical Analgesic

FDA APPROVED NON-PRESCRIPTION PAIN RELIEVING PATCH
EFFECTIVENESS CONFIRMED IN CLINICAL TRIAL

1 patch
2 3/4" X 3 15/16" (7cm X 10cm)

Package not child resistant.
Keep out of reach of children.

*DO NOT USE MORE THAN ONE SALONPAS PATCH AT A TIME, SEE DIRECTIONS

Manufactured by
Hisamitsu Pharmaceutical Co., Inc.
JAPAN SAGA TOSU
MADE IN JAPAN

Distributed by
Hisamitsu America, Inc.
Florham Park, NJ 07932

FREE SAMPLE
NOT FOR RE-SALE

image of 1-patch sample pouch label

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	SPL version
853146	menthol 3 % / methyl salicylate 10 % Medicated Patch	PSN	5
853146	menthol 0.03 MG/MG / methyl salicylate 0.1 MG/MG Medicated Patch	SCD	5
853146	menthol 3 % / methyl salicylate 10 % Medicated Patch	SY	5

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
dea2eded-d1e7-46bb-9a3d-f8dc20de6277	Product name	1	20190408

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
46581-680-01	2025-03-13	C162847	48780-1	2cef2736-8b92-d83d-e063-dadaa90ab31f	2e88c933-89e6-4a48-be7a-dc6a36e5c8f8
46581-680-03	2025-03-13	C162847	48780-1	2cef2736-8b92-d83d-e063-dadaa90ab31f	2e88c933-89e6-4a48-be7a-dc6a36e5c8f8
46581-680-05	2025-03-13	C162847	48780-1	2cef2736-8b92-d83d-e063-dadaa90ab31f	2e88c933-89e6-4a48-be7a-dc6a36e5c8f8
46581-680-15	2025-03-13	C162847	48780-1	2cef2736-8b92-d83d-e063-dadaa90ab31f	2e88c933-89e6-4a48-be7a-dc6a36e5c8f8
46581-680-20	2025-03-13	C162847	48780-1	2cef2736-8b92-d83d-e063-dadaa90ab31f	2e88c933-89e6-4a48-be7a-dc6a36e5c8f8
46581-680-99	2025-03-13	C162847	48780-1	2cef2736-8b92-d83d-e063-dadaa90ab31f	2e88c933-89e6-4a48-be7a-dc6a36e5c8f8
46581-680-01	2025-01-30	C162847	48780-1	2cef2736-8b92-d83d-e063-dadaa90ab31f	2e88c933-89e6-4a48-be7a-dc6a36e5c8f8
46581-680-03	2025-01-30	C162847	48780-1	2cef2736-8b92-d83d-e063-dadaa90ab31f	2e88c933-89e6-4a48-be7a-dc6a36e5c8f8
46581-680-05	2025-01-30	C162847	48780-1	2cef2736-8b92-d83d-e063-dadaa90ab31f	2e88c933-89e6-4a48-be7a-dc6a36e5c8f8
46581-680-15	2025-01-30	C162847	48780-1	2cef2736-8b92-d83d-e063-dadaa90ab31f	2e88c933-89e6-4a48-be7a-dc6a36e5c8f8
46581-680-20	2025-01-30	C162847	48780-1	2cef2736-8b92-d83d-e063-dadaa90ab31f	2e88c933-89e6-4a48-be7a-dc6a36e5c8f8
46581-680-99	2025-01-30	C162847	48780-1	2cef2736-8b92-d83d-e063-dadaa90ab31f	2e88c933-89e6-4a48-be7a-dc6a36e5c8f8

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
46581-680	SALONPAS ARTHRITIS PAIN (MENTHOL, METHYL SALICYLATE) PATCH [HISAMITSU PHARMACEUTICAL CO., INC.]	5	Current NDC, Legacy NDC	20250316_2e88c933-89e6-4a48-be7a-dc6a36e5c8f8.zip

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
46581-680-05	EA - Each	46581-680	eef1692f-7294-4253-91af-0d24190b4791	1	2015-10-02

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	SPL version
MENTHOL	ACTIVE INGREDIENT	L7T10EIP3A	2
METHYL SALICYLATE	ACTIVE INGREDIENT	LAV5U5022Y	2
MENTHOL	ACTIVE MOIETY	L7T10EIP3A	2
SALICYLIC ACID	ACTIVE MOIETY	O414PZ4LPZ	2
ALUMINUM SILICATE	INACTIVE INGREDIENT	T1FAD4SS2M	2
MINERAL OIL	INACTIVE INGREDIENT	T5L8T28FGP	2

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 7 matching rows.

Salonpas Arthritis Pain
Menthol, Methyl Salicylate
MENTHOL
METHYL SALICYLATE
SALICYLIC ACID
ALUMINUM SILICATE
MINERAL OIL

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
46581-680	46581-680-15, 46581-680-05, 46581-680-20, 46581-680-03, 46581-680-01, 46581-680-99

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 4 matching rows.

Name, UNII, Kind table
Name	UNII	Kind
MENTHOL	L7T10EIP3A	ACTIB
METHYL SALICYLATE	LAV5U5022Y	ACTIB
ALUMINUM SILICATE	T1FAD4SS2M	IACT
MINERAL OIL	T5L8T28FGP	IACT

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 2 · 98 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredient	IID ingredient	UNII	Dosage form / route	Potency	Maximum daily exposure	Match
MINERAL OIL	MINERAL OIL	T5L8T28FGP	SOAP / TOPICAL	0.82 %w/w		Exact identifier — unii+route 91 equally ranked IID candidates
MINERAL OIL	MINERAL OIL	T5L8T28FGP	SYSTEM / TRANSDERMAL	6.09 mg		Exact identifier — unii+route 91 equally ranked IID candidates
MINERAL OIL	MINERAL OIL	T5L8T28FGP	FILM / TRANSDERMAL	11.42 mg		Exact identifier — unii+route 91 equally ranked IID candidates
MINERAL OIL	MINERAL OIL	T5L8T28FGP	GEL / TOPICAL	2.5 %w/w		Exact identifier — unii+route 91 equally ranked IID candidates
ALUMINUM SILICATE	ALUMINUM SILICATE	T1FAD4SS2M	SYSTEM / TOPICAL		19 mg	Exact identifier — unii+route 7 equally ranked IID candidates
MINERAL OIL	MINERAL OIL	T5L8T28FGP	GEL / TOPICAL	2.5 %w/w		Exact identifier — unii+route 91 equally ranked IID candidates
ALUMINUM SILICATE	ALUMINUM SILICATE	T1FAD4SS2M	SYSTEM / TOPICAL		19 mg	Exact identifier — unii+route 7 equally ranked IID candidates
MINERAL OIL	MINERAL OIL	T5L8T28FGP	GEL / TOPICAL	2.5 %w/w		Exact identifier — unii+route 91 equally ranked IID candidates
MINERAL OIL	MINERAL OIL	T5L8T28FGP	SUSPENSION / TOPICAL	82 %w/w		Exact identifier — unii+route 91 equally ranked IID candidates
MINERAL OIL	MINERAL OIL	T5L8T28FGP	SPRAY / TOPICAL		1379 mg	Exact identifier — unii+route 91 equally ranked IID candidates
MINERAL OIL	MINERAL OIL	T5L8T28FGP	SYSTEM / TOPICAL	654.36 mg		Exact identifier — unii+route 91 equally ranked IID candidates
MINERAL OIL	MINERAL OIL	T5L8T28FGP	FILM / TRANSDERMAL	11.42 mg		Exact identifier — unii+route 91 equally ranked IID candidates
MINERAL OIL	MINERAL OIL	T5L8T28FGP	CREAM / TOPICAL		2772 mg	Exact identifier — unii+route 91 equally ranked IID candidates
MINERAL OIL	MINERAL OIL	T5L8T28FGP	LOTION / TOPICAL		1428 mg	Exact identifier — unii+route 91 equally ranked IID candidates
MINERAL OIL	MINERAL OIL	T5L8T28FGP	OIL / TOPICAL	43.29 %v/v		Exact identifier — unii+route 91 equally ranked IID candidates
MINERAL OIL	MINERAL OIL	T5L8T28FGP	LOTION / TOPICAL		1428 mg	Exact identifier — unii+route 91 equally ranked IID candidates
MINERAL OIL	MINERAL OIL	T5L8T28FGP	PASTE / TOPICAL	47.5 %w/w		Exact identifier — unii+route 91 equally ranked IID candidates
MINERAL OIL	MINERAL OIL	T5L8T28FGP	FILM / TRANSDERMAL	11.42 mg		Exact identifier — unii+route 91 equally ranked IID candidates
ALUMINUM SILICATE	ALUMINUM SILICATE	T1FAD4SS2M	SYSTEM / TOPICAL		19 mg	Exact identifier — unii+route 7 equally ranked IID candidates
MINERAL OIL	MINERAL OIL	T5L8T28FGP	PASTE / TOPICAL	47.5 %w/w		Exact identifier — unii+route 91 equally ranked IID candidates
MINERAL OIL	MINERAL OIL	T5L8T28FGP	OINTMENT / TOPICAL		9938 mg	Exact identifier — unii+route 91 equally ranked IID candidates
MINERAL OIL	MINERAL OIL	T5L8T28FGP	SYSTEM / TOPICAL	654.36 mg		Exact identifier — unii+route 91 equally ranked IID candidates
MINERAL OIL	MINERAL OIL	T5L8T28FGP	SYSTEM / TRANSDERMAL	6.09 mg		Exact identifier — unii+route 91 equally ranked IID candidates
MINERAL OIL	MINERAL OIL	T5L8T28FGP	FILM, EXTENDED RELEASE / TRANSDERMAL	34 mg		Exact identifier — unii+route 91 equally ranked IID candidates
ALUMINUM SILICATE	ALUMINUM SILICATE	T1FAD4SS2M	SYSTEM / TOPICAL		19 mg	Exact identifier — unii+route 7 equally ranked IID candidates
MINERAL OIL	MINERAL OIL	T5L8T28FGP	CREAM / TOPICAL		2772 mg	Exact identifier — unii+route 91 equally ranked IID candidates
MINERAL OIL	MINERAL OIL	T5L8T28FGP	SYSTEM / TOPICAL	654.36 mg		Exact identifier — unii+route 91 equally ranked IID candidates
MINERAL OIL	MINERAL OIL	T5L8T28FGP	PASTE / TOPICAL	47.5 %w/w		Exact identifier — unii+route 91 equally ranked IID candidates
MINERAL OIL	MINERAL OIL	T5L8T28FGP	OIL / TOPICAL	43.29 %v/v		Exact identifier — unii+route 91 equally ranked IID candidates
MINERAL OIL	MINERAL OIL	T5L8T28FGP	OIL / TOPICAL	43.29 %v/v		Exact identifier — unii+route 91 equally ranked IID candidates
MINERAL OIL	MINERAL OIL	T5L8T28FGP	SUSPENSION / TOPICAL	82 %w/w		Exact identifier — unii+route 91 equally ranked IID candidates
MINERAL OIL	MINERAL OIL	T5L8T28FGP	OIL / TOPICAL	43.29 %v/v		Exact identifier — unii+route 91 equally ranked IID candidates
MINERAL OIL	MINERAL OIL	T5L8T28FGP	SPRAY / TOPICAL		1379 mg	Exact identifier — unii+route 91 equally ranked IID candidates
MINERAL OIL	MINERAL OIL	T5L8T28FGP	LOTION / TOPICAL		1428 mg	Exact identifier — unii+route 91 equally ranked IID candidates
MINERAL OIL	MINERAL OIL	T5L8T28FGP	OIL / TOPICAL	43.29 %v/v		Exact identifier — unii+route 91 equally ranked IID candidates
MINERAL OIL	MINERAL OIL	T5L8T28FGP	PASTE / TOPICAL	47.5 %w/w		Exact identifier — unii+route 91 equally ranked IID candidates
MINERAL OIL	MINERAL OIL	T5L8T28FGP	SOAP / TOPICAL	0.82 %w/w		Exact identifier — unii+route 91 equally ranked IID candidates
MINERAL OIL	MINERAL OIL	T5L8T28FGP	SYSTEM / TOPICAL	654.36 mg		Exact identifier — unii+route 91 equally ranked IID candidates
MINERAL OIL	MINERAL OIL	T5L8T28FGP	OINTMENT / TOPICAL		9938 mg	Exact identifier — unii+route 91 equally ranked IID candidates
ALUMINUM SILICATE	ALUMINUM SILICATE	T1FAD4SS2M	SYSTEM / TOPICAL		19 mg	Exact identifier — unii+route 7 equally ranked IID candidates
MINERAL OIL	MINERAL OIL	T5L8T28FGP	FILM / TRANSDERMAL	11.42 mg		Exact identifier — unii+route 91 equally ranked IID candidates
MINERAL OIL	MINERAL OIL	T5L8T28FGP	SUSPENSION / TOPICAL	82 %w/w		Exact identifier — unii+route 91 equally ranked IID candidates
MINERAL OIL	MINERAL OIL	T5L8T28FGP	FILM, EXTENDED RELEASE / TRANSDERMAL	34 mg		Exact identifier — unii+route 91 equally ranked IID candidates
MINERAL OIL	MINERAL OIL	T5L8T28FGP	SPRAY / TOPICAL		1379 mg	Exact identifier — unii+route 91 equally ranked IID candidates
MINERAL OIL	MINERAL OIL	T5L8T28FGP	CREAM / TOPICAL		2772 mg	Exact identifier — unii+route 91 equally ranked IID candidates
MINERAL OIL	MINERAL OIL	T5L8T28FGP	SYSTEM / TOPICAL	654.36 mg		Exact identifier — unii+route 91 equally ranked IID candidates
MINERAL OIL	MINERAL OIL	T5L8T28FGP	FILM / TRANSDERMAL	11.42 mg		Exact identifier — unii+route 91 equally ranked IID candidates
MINERAL OIL	MINERAL OIL	T5L8T28FGP	SYSTEM / TRANSDERMAL	6.09 mg		Exact identifier — unii+route 91 equally ranked IID candidates
MINERAL OIL	MINERAL OIL	T5L8T28FGP	SPRAY / TOPICAL		1379 mg	Exact identifier — unii+route 91 equally ranked IID candidates
MINERAL OIL	MINERAL OIL	T5L8T28FGP	PASTE / TOPICAL	47.5 %w/w		Exact identifier — unii+route 91 equally ranked IID candidates
MINERAL OIL	MINERAL OIL	T5L8T28FGP	GEL / TOPICAL	2.5 %w/w		Exact identifier — unii+route 91 equally ranked IID candidates
MINERAL OIL	MINERAL OIL	T5L8T28FGP	SUSPENSION / TOPICAL	82 %w/w		Exact identifier — unii+route 91 equally ranked IID candidates
MINERAL OIL	MINERAL OIL	T5L8T28FGP	LOTION / TOPICAL		1428 mg	Exact identifier — unii+route 91 equally ranked IID candidates
MINERAL OIL	MINERAL OIL	T5L8T28FGP	SUSPENSION / TOPICAL	82 %w/w		Exact identifier — unii+route 91 equally ranked IID candidates
MINERAL OIL	MINERAL OIL	T5L8T28FGP	SOAP / TOPICAL	0.82 %w/w		Exact identifier — unii+route 91 equally ranked IID candidates
MINERAL OIL	MINERAL OIL	T5L8T28FGP	SYSTEM / TRANSDERMAL	6.09 mg		Exact identifier — unii+route 91 equally ranked IID candidates
MINERAL OIL	MINERAL OIL	T5L8T28FGP	OINTMENT / TOPICAL		9938 mg	Exact identifier — unii+route 91 equally ranked IID candidates
MINERAL OIL	MINERAL OIL	T5L8T28FGP	OIL / TOPICAL	43.29 %v/v		Exact identifier — unii+route 91 equally ranked IID candidates
ALUMINUM SILICATE	ALUMINUM SILICATE	T1FAD4SS2M	SYSTEM / TOPICAL		19 mg	Exact identifier — unii+route 7 equally ranked IID candidates
MINERAL OIL	MINERAL OIL	T5L8T28FGP	CREAM / TOPICAL		2772 mg	Exact identifier — unii+route 91 equally ranked IID candidates

Orange Book application contexts#

All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.

Orange Book application contexts page 1 of 1 · 1 matching rows.

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
N022029-001	SALONPAS	MENTHOL; METHYL SALICYLATE	3%;10%	PATCH / TOPICAL		RLD, RS	2008-02-20
N022029-002	SALONPAS	MENTHOL; METHYL SALICYLATE	3%;10%	PATCH / TOPICAL		RLD, RS	2012-11-05

Orange Book patents#

Current patent rows page 1 of 1 · 4 matching rows.

Application-product, Patent, Expiration table
Application-product	Patent	Expiration	Coverage / status	Submission date
N022029-001	9233184	2027-08-01	Drug product	2016-02-11
N022029-001	8809615	2030-01-03	Drug product	2014-08-19
N022029-002	9233184	2027-08-01	Drug product	2016-02-11
N022029-002	8809615	2030-01-03	Drug product	2014-08-19

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 3 · 86 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	RLD / RS	Approval date	Source SHA-256
2026-09-14 22:38:34	2026-08	N022029-001	SALONPAS	3%;10%	PATCH / TOPICAL	RLD, RS	2008-02-20	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N022029-002	SALONPAS	3%;10%	PATCH / TOPICAL	RLD, RS	2012-11-05	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	N022029-001	SALONPAS	3%;10%	PATCH / TOPICAL	RLD, RS	2008-02-20	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N022029-002	SALONPAS	3%;10%	PATCH / TOPICAL	RLD, RS	2012-11-05	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N022029-001	SALONPAS	3%;10%	PATCH / TOPICAL	RLD, RS	2008-02-20	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N022029-002	SALONPAS	3%;10%	PATCH / TOPICAL	RLD	2012-11-05	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N022029-001	SALONPAS	3%;10%	PATCH / TOPICAL	RLD, RS	2008-02-20	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N022029-002	SALONPAS	3%;10%	PATCH / TOPICAL	RLD	2012-11-05	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N022029-001	SALONPAS	3%;10%	PATCH / TOPICAL	RLD, RS	2008-02-20	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N022029-002	SALONPAS	3%;10%	PATCH / TOPICAL	RLD	2012-11-05	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N022029-001	SALONPAS	3%;10%	PATCH / TOPICAL	RLD, RS	2008-02-20	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N022029-002	SALONPAS	3%;10%	PATCH / TOPICAL	RLD	2012-11-05	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N022029-001	SALONPAS	3%;10%	PATCH / TOPICAL	RLD, RS	2008-02-20	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N022029-002	SALONPAS	3%;10%	PATCH / TOPICAL	RLD	2012-11-05	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N022029-001	SALONPAS	3%;10%	PATCH / TOPICAL	RLD, RS	2008-02-20	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N022029-002	SALONPAS	3%;10%	PATCH / TOPICAL	RLD	2012-11-05	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N022029-001	SALONPAS	3%;10%	PATCH / TOPICAL	RLD, RS	2008-02-20	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N022029-002	SALONPAS	3%;10%	PATCH / TOPICAL	RLD	2012-11-05	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N022029-001	SALONPAS	3%;10%	PATCH / TOPICAL	RLD, RS	2008-02-20	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N022029-002	SALONPAS	3%;10%	PATCH / TOPICAL	RLD	2012-11-05	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N022029-001	SALONPAS	3%;10%	PATCH / TOPICAL	RLD, RS	2008-02-20	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N022029-002	SALONPAS	3%;10%	PATCH / TOPICAL	RLD	2012-11-05	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N022029-001	SALONPAS	3%;10%	PATCH / TOPICAL	RLD, RS	2008-02-20	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N022029-002	SALONPAS	3%;10%	PATCH / TOPICAL	RLD	2012-11-05	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N022029-001	SALONPAS	3%;10%	PATCH / TOPICAL	RLD, RS	2008-02-20	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N022029-002	SALONPAS	3%;10%	PATCH / TOPICAL	RLD	2012-11-05	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N022029-001	SALONPAS	3%;10%	PATCH / TOPICAL	RLD, RS	2008-02-20	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N022029-002	SALONPAS	3%;10%	PATCH / TOPICAL	RLD	2012-11-05	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N022029-001	SALONPAS	3%;10%	PATCH / TOPICAL	RLD, RS	2008-02-20	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N022029-002	SALONPAS	3%;10%	PATCH / TOPICAL	RLD	2012-11-05	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N022029-001	SALONPAS	3%;10%	PATCH / TOPICAL	RLD, RS	2008-02-20	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	N022029-002	SALONPAS	3%;10%	PATCH / TOPICAL	RLD	2012-11-05	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N022029-001	SALONPAS	3%;10%	PATCH / TOPICAL	RLD, RS	2008-02-20	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N022029-002	SALONPAS	3%;10%	PATCH / TOPICAL	RLD	2012-11-05	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	N022029-001	SALONPAS	3%;10%	PATCH / TOPICAL	RLD, RS	2008-02-20	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	N022029-002	SALONPAS	3%;10%	PATCH / TOPICAL	RLD	2012-11-05	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	N022029-001	SALONPAS	3%;10%	PATCH / TOPICAL	RLD, RS	2008-02-20	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	N022029-002	SALONPAS	3%;10%	PATCH / TOPICAL	RLD	2012-11-05	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	N022029-001	SALONPAS	3%;10%	PATCH / TOPICAL	RLD, RS	2008-02-20	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N022029-002	SALONPAS	3%;10%	PATCH / TOPICAL	RLD	2012-11-05	`74a2ff9319b5…`

Observed Orange Book patent history#

Patent history page 1 of 5 · 172 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Patent	Expiration	Coverage / status	Submission date	Source SHA-256
2026-09-14 22:38:34	2026-08	N022029-001	9233184	2027-08-01	Drug product	2016-02-11	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N022029-001	8809615	2030-01-03	Drug product	2014-08-19	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N022029-002	9233184	2027-08-01	Drug product	2016-02-11	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N022029-002	8809615	2030-01-03	Drug product	2014-08-19	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	N022029-001	9233184	2027-08-01	Drug product	2016-02-11	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N022029-001	8809615	2030-01-03	Drug product	2014-08-19	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N022029-002	9233184	2027-08-01	Drug product	2016-02-11	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N022029-002	8809615	2030-01-03	Drug product	2014-08-19	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N022029-001	9233184	2027-08-01	Drug product	2016-02-11	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N022029-001	8809615	2030-01-03	Drug product	2014-08-19	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N022029-002	9233184	2027-08-01	Drug product	2016-02-11	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N022029-002	8809615	2030-01-03	Drug product	2014-08-19	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N022029-001	9233184	2027-08-01	Drug product	2016-02-11	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N022029-001	8809615	2030-01-03	Drug product	2014-08-19	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N022029-002	9233184	2027-08-01	Drug product	2016-02-11	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N022029-002	8809615	2030-01-03	Drug product	2014-08-19	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N022029-001	9233184	2027-08-01	Drug product	2016-02-11	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N022029-001	8809615	2030-01-03	Drug product	2014-08-19	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N022029-002	9233184	2027-08-01	Drug product	2016-02-11	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N022029-002	8809615	2030-01-03	Drug product	2014-08-19	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N022029-001	9233184	2027-08-01	Drug product	2016-02-11	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N022029-001	8809615	2030-01-03	Drug product	2014-08-19	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N022029-002	9233184	2027-08-01	Drug product	2016-02-11	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N022029-002	8809615	2030-01-03	Drug product	2014-08-19	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N022029-001	9233184	2027-08-01	Drug product	2016-02-11	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N022029-001	8809615	2030-01-03	Drug product	2014-08-19	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N022029-002	9233184	2027-08-01	Drug product	2016-02-11	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N022029-002	8809615	2030-01-03	Drug product	2014-08-19	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N022029-001	9233184	2027-08-01	Drug product	2016-02-11	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N022029-001	8809615	2030-01-03	Drug product	2014-08-19	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N022029-002	9233184	2027-08-01	Drug product	2016-02-11	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N022029-002	8809615	2030-01-03	Drug product	2014-08-19	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N022029-001	9233184	2027-08-01	Drug product	2016-02-11	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N022029-001	8809615	2030-01-03	Drug product	2014-08-19	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N022029-002	9233184	2027-08-01	Drug product	2016-02-11	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N022029-002	8809615	2030-01-03	Drug product	2014-08-19	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N022029-001	9233184	2027-08-01	Drug product	2016-02-11	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N022029-001	8809615	2030-01-03	Drug product	2014-08-19	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N022029-002	9233184	2027-08-01	Drug product	2016-02-11	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N022029-002	8809615	2030-01-03	Drug product	2014-08-19	`5bbf6a4d5a75…`

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Salonpas Arthritis Pain	MENTHOL, METHYL SALICYLATE	Hisamitsu Pharmaceutical Co., Inc.	2e88c933-89e6-4a48-be7a-dc6a36e5c8f8	2025-03-14	Warnings	Exact identifier ndc (package): 46581-680-20 ndc (package): 46581-680-03 ndc (package): 46581-680-01 ndc (package): 46581-680-99 ndc (package): 46581-680-05 ndc (package): 46581-680-15 ndc (product): 46581-680 ndc11 (package): 46581068099 ndc11 (package): 46581068003 ndc11 (package): 46581068020 ndc11 (package): 46581068001 ndc11 (package): 46581068015 ndc11 (package): 46581068005 spl id: bcc483db-24c1-40ec-964a-7e97dfe913ee spl set id: 2e88c933-89e6-4a48-be7a-dc6a36e5c8f8

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.